Publication: Uric acid in metabolic syndrome: from an innocent bystander to a central player
dc.contributor.coauthor | Jensen, Thomas | |
dc.contributor.coauthor | Solak, Yalçın | |
dc.contributor.coauthor | Le, Myphuong | |
dc.contributor.coauthor | Roncal-Jimenez, Carlos | |
dc.contributor.coauthor | Rivard, Chris | |
dc.contributor.coauthor | Lanaspa, Miguel A. | |
dc.contributor.coauthor | Nakagawa, Takahiko | |
dc.contributor.coauthor | Johnson, Richard J. | |
dc.contributor.department | School of Medicine | |
dc.contributor.kuauthor | Acar, Ömer | |
dc.contributor.kuauthor | Esen, Tarık | |
dc.contributor.kuauthor | Kanbay, Mehmet | |
dc.contributor.kuauthor | Kiremit, Murat Can | |
dc.contributor.kuauthor | Sağ, Alan Alper | |
dc.contributor.kuauthor | Tarım, Kayhan | |
dc.contributor.schoolcollegeinstitute | SCHOOL OF MEDICINE | |
dc.date.accessioned | 2024-11-09T23:12:20Z | |
dc.date.issued | 2016 | |
dc.description.abstract | Uric acid, once viewed as an inert metabolic end-product of purinemetabolism, has been recently incriminated in a number of chronic disease states, including hypertension, metabolic syndrome, diabetes, non- alcoholic fatty liver disease, and chronic kidney disease. Several experimental and clinical studies support a role for uric acid as a contributory causal factor in these conditions. Here we discuss some of the major mechanisms linking uric acid to metabolic and cardiovascular diseases. At this time the key to understanding the importance of uric acid in these diseases will be the conduct of large clinical trials in which the effect of lowering uric acid on hard clinical outcomes is assessed. Elevated uric acid may turn out to be one of the more important remediable risk factors for metabolic and cardiovascular diseases. | |
dc.description.indexedby | WOS | |
dc.description.indexedby | Scopus | |
dc.description.indexedby | PubMed | |
dc.description.openaccess | YES | |
dc.description.publisherscope | International | |
dc.description.sponsoredbyTubitakEu | N/A | |
dc.description.sponsorship | NIDDK NIH HHS [K01 DK095930, R03 DK105041] Funding Source: Medline | |
dc.description.volume | 29 | |
dc.identifier.doi | 10.1016/j.ejim.2015.11.026 | |
dc.identifier.eissn | 1879-0828 | |
dc.identifier.issn | 0953-6205 | |
dc.identifier.quartile | Q1 | |
dc.identifier.scopus | 2-s2.0-84950282194 | |
dc.identifier.uri | https://doi.org/10.1016/j.ejim.2015.11.026 | |
dc.identifier.uri | https://hdl.handle.net/20.500.14288/9785 | |
dc.identifier.wos | 373718800013 | |
dc.keywords | Uric acid | |
dc.keywords | Metabolic syndrome | |
dc.keywords | Hypertension | |
dc.keywords | Diabetes mellitus | |
dc.keywords | Kidney disease | |
dc.keywords | Cardiovascular disease | |
dc.keywords | Fatty liver-disease | |
dc.keywords | Glucose-sweetened beverages | |
dc.keywords | Muscle-cell-proliferation | |
dc.keywords | Chronic kidney-disease | |
dc.keywords | Blood-pressure | |
dc.keywords | Oxidative stress | |
dc.keywords | Cardiovascular-disease | |
dc.keywords | Endothelial dysfunction | |
dc.keywords | Nitric-oxide | |
dc.keywords | Risk-factors | |
dc.language.iso | eng | |
dc.publisher | Elsevier | |
dc.relation.ispartof | European Journal of Internal Medicine | |
dc.subject | Medicine | |
dc.subject | General and internal medicine | |
dc.title | Uric acid in metabolic syndrome: from an innocent bystander to a central player | |
dc.type | Review | |
dspace.entity.type | Publication | |
local.contributor.kuauthor | Kanbay, Mehmet | |
local.contributor.kuauthor | Kiremit, Murat Can | |
local.contributor.kuauthor | Acar, Ömer | |
local.contributor.kuauthor | Esen, Tarık | |
local.contributor.kuauthor | Sağ, Alan Alper | |
local.contributor.kuauthor | Tarım, Kayhan | |
local.publication.orgunit1 | SCHOOL OF MEDICINE | |
local.publication.orgunit2 | School of Medicine | |
relation.isOrgUnitOfPublication | d02929e1-2a70-44f0-ae17-7819f587bedd | |
relation.isOrgUnitOfPublication.latestForDiscovery | d02929e1-2a70-44f0-ae17-7819f587bedd | |
relation.isParentOrgUnitOfPublication | 17f2dc8e-6e54-4fa8-b5e0-d6415123a93e | |
relation.isParentOrgUnitOfPublication.latestForDiscovery | 17f2dc8e-6e54-4fa8-b5e0-d6415123a93e |